Although inhibition of KDM5C could have adverse effects on neuronal circuits [62] or promote tumor formation in clear cell renal carcinoma [63] and cervical cancer [64], KDM5C was also shown to have oncogenic roles in prostate cancer [65]. This evidence concerns the gene KDM5C and prostate cancer.